ADVISORY/Cytokinetics, Inc. Announces June 27th Briefing on GlaxoSmithKline Strategic Alliance.Business Editors/Health & Medical Writers ADVISORY... for Wednesday (June 27) SOUTH SAN FRANCISCO South San Francisco, city (1990 pop. 54,312), San Mateo co., W Calif.; inc. 1908. South San Francisco has several industrial parks; its manufactures include medical supplies and equipment, foods, paint, paper products, consumer goods, and clothing. , Calif.--(BW HealthWire)--June 25, 2001 Collaboration Will Establish the Leading Cancer Drug Discovery Program in the Emerging Field of Mitotic mitotic pertaining to mitosis. mitotic activity degree to which a cell population is proliferating; used as an index of tumor aggression. Kinesin Inhibitors Cytokinetics, Inc., is pleased to invite journalists, financial analysts and investors to attend a lunch briefing on June 27 regarding today's announced collaboration with GlaxoSmithKline (GSK GSK GlaxoSmithKline plc (pharmaceutical company) GSK Glycogen Synthase Kinase GSK Gruppentraining Sozialer Kompetenzen (Germany) GSK Greenland Shark (FAO fish species code) ). Through this strategic alliance, Cytokinetics will combine its foremost position in the biology and pharmacology of mitotic kinesins with the advanced pharmaceutical discovery, development and commercialization capabilities of GSK to build the leading initiative in the field of mitotic kinesin inhibitors. Cytokinetics management will discuss the scope and terms of today's announced partnership. In addition, leading researchers will provide background on the emerging field of mitotic kinesin inhibitors and elaborate on their therapeutic potential. Information regarding the event follows. Seating will be limited; please RSVP (ReSerVation Protocol) A communications protocol that signals a router to reserve bandwidth for real time transmission. RSVP is designed to clear a path for audio and video traffic, eliminating annoying skips and hesitations. in advance with Justin Jackson, 212/213-0006, or Margaret Wahle, 415/352-6262, both of Burns McClellan.
DATE: Wednesday, June 27, 2001
TIME: 12:00 p.m. - 2:00 p.m. Eastern
LOCATION: The Four Seasons Hotel
Cosmopolitan Room
57 East 57th Street
New York, NY
(Between Park and Madison Avenues)
Founded in 1998 and privately-held, Cytokinetics is dedicated to the discovery, development and commercialization of a novel class of therapeutics resulting from its leadership position in the emerging field of cytoskeletal cy`to`skel´e`tal a. 1. (Cell Biology) Of or pertaining to the cytoskeleton; as, cytoskeletal microtubules s>. pharmacology. The cytoskeleton cytoskeleton System of microscopic filaments or fibres, present in the cytoplasm of eukaryotic cells (see eukaryote), that organizes other cell components, maintains cell shape, and is responsible for cell locomotion and for movement of the organelles within it. is a complex, dynamic framework that impacts all aspects of cell function including cell division, cell motility, intracellular transport, muscle contractility contractility /con·trac·til·i·ty/ (kon?trak-til´i-te) capacity for becoming shorter in response to a suitable stimulus. contractility a capacity for becoming short in response to suitable stimulus. and regulation of cellular organization. Cytokinetics' R&D efforts incorporate proprietary Cytometrix(TM) automated cell biology technologies and are focused on serving pharmaceutical needs in cancer, cardiovascular and infectious diseases. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion